1199-49-1

Basic information

• Product Name: 1,2,4-Oxadiazole, 3-(1-methylethyl)-5-(trichloromethyl)-
• CAS NO: 1199-49-1
• Molecular Formula: C6H7Cl3N2O
• Molecular Weight: 229.493
• Mol File: 1199-49-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1,2,4-Oxadiazole, 3-(1-methylethyl)-5-(trichloromethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,4-Oxadiazole, 3-(1-methylethyl)-5-(trichloromethyl)-(1199-49-1)
• EPA Substance Registry System: 1,2,4-Oxadiazole, 3-(1-methylethyl)-5-(trichloromethyl)-(1199-49-1)

Safety Data

• Hazardous Substances Data: 1199-49-1(Hazardous Substances Data)

Usage

General Description

1,2,4-Oxadiazole, 3-(1-methylethyl)-5-(trichloromethyl)- is a chemical compound with the molecular formula C7H7Cl3N2O. It is a member of the oxadiazole family and is characterized by the presence of a trichloromethyl functional group. 1,2,4-Oxadiazole, 3-(1-methylethyl)-5-(trichloromethyl)- has potential applications in the field of pharmaceuticals, as it has been studied for its antimicrobial, antitumor, and anticonvulsant properties. Additionally, it has also been investigated for its potential use as a pesticide and herbicide. Research on this compound is ongoing to explore its various potential applications and properties.

Upstream product

• 76-02-8 trifluoroacetyl chloride 
• 849833-56-3 N-hydroxyisobutyramidine 
• 4124-31-6 trichloroacetic acid anhydride 

Downstream Products

• 1188446-94-7 tert-butyl 4-(3-isopropyl-1,2,4-oxadiazol-5-yloxy)benzylcarbamate 
• 1188446-96-9 (4-(3-isopropyl-1,2,4-oxadiazol-5-yloxy)phenyl)methanamine 
• 1032824-43-3 2-[((1S)-1-{1-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}ethyl)oxy]-5-[4-(methylsulfonyl)phenyl]pyrazine 
• 1032823-75-8 ((5-[({1-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}methyl)oxy]-2-[4-(methylsulfonyl)phenyl]pyridine)) 
• 1351343-10-6 [(3R,4S)-1-{5-[1-(3-isopropyl-[1,2,4]oxadiazole-5-carbonyl)piperidin-4-ylmethoxy]pyrimidin-2-yl}-4-(2,4,5-trifluoro-phenyl)pyrrolidin-3-yl]carbamic acid tert-butyl ester 
• 52366-04-8 3-isopropyl-1,2,4-oxadiazol-5-ol 

Relevant articles and documents

Benzo [d] [1, 3] oxathiol, benzo [d] [1, 3] benzo [d] [1, 3] oxathiol 3 - oxide or 3, 3 - dioxide compounds and G protein-coupled receptor 119 oxathiol action of number as method/use

There are provided compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide, and benzo[d][1,3]oxathiole 3,3-dioxide, as well as uses/methods related thereto, including treatment of diseases and condition associated with GPR119 dysregulation, Type 2 diabetes mellitus, and related metabolic disorders.

OXADIAZOLE COMPOUNDS

The present invention relates to a compound of formula (I) or (II) or a stereoisomer, enantiomer, racemic, or tautomer thereof, (I) (II) wherein R1,R2,R3,L1,L2,L3,L4,L5 and n, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of metabolic disorders and/or neurodegenerative diseases, and/or protein misfolding disorders.

BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS

The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.